Table 3.
Genetic glycoengineering | Glycosyltransferase glycoengineering | Chemoenzymatic glycoengineering | |
---|---|---|---|
Strategies | Modify intracellular glycosylation pathways and enzymes via genetic engineering. | Extend monosaccharide residues by glycosyltransferases in vitro. | Modify sugar chains by endoglycosidases and their mutants, together with chemically synthesized active glycan oxazolines. |
Methods | Remold sialyltransferases; increase CMP-Neu5Ac-associated enzymes or transporters; inhibit or eliminate sialidases; introduce new N-glycosylation sites. | Construct one-pot system with monosaccharide precursors and glycosyltransferases. | Deglycosylate IgG by an ENGase, prepare oxazoline derivatives as sugars donors via chemical methods, and transglycosylate oxazoline donor to glycoprotein. |
Pros | Versatility | Simplicity and relatively purified products. | Simplicity; relatively purified and unlimited products. |
Cons | Low efficiency and hybrid glyco-products | Limited glyco-products; difficulty and high cost of active glycan substrates. | Unavoidable hydrolytic activity of ENGase mutant; difficult to achieve oligosaccharide substrates in a large scale. |
CMP, cytidine monophosphate; Neu5Ac, N-acetylneuraminic acid; ENGase, endoglycosidase.